Resmed Inc. buy Morgan Stanley
Start price
27.10.23
/
50%
€126.35
Target price
27.10.24
€160.06
Performance (%)
51.67%
Price
03.06.24
€190.30
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Resmed Inc. has seen massive gains of 51.67%. Dividends of €1.34 are taken into consideration when calculating the performance. This prediction currently runs until 27.10.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -3.231% | -3.231% |
| iShares Core DAX® | -0.552% | 3.281% |
| iShares Nasdaq 100 | -1.415% | 4.535% |
| iShares Nikkei 225® | -0.877% | -1.739% |
| iShares S&P 500 | -0.415% | 3.239% |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $169.00 price target on the stock, down previously from $180.00.
Ratings data for RMD provided by MarketBeat